-
Clinical and Experimental Gastroenterology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Time trends in incidence of peptic ulcer bleeding and associated risk factors in Norway 1985–2008
Original Research
(1979) Views (518) Full article downloads
Authors: Kåre E Bakkevold
Published Date June 2010
Volume 2010:3 Pages 71 - 77
DOI: http://dx.doi.org/10.2147/CEG.S10921
Kåre E Bakkevold
Department of Surgery, Haugesund Hospital, Haugesund, Norway
Objective: The aim of this study was to examine time trends in the incidence of peptic ulcer bleeding and risk factors in a defined geographical area in Norway.
Material and methods: Retrospective data were collected for 306 patients with bleeding peptic ulcers admitted to one hospital during the 1985–1986, 1995–1996, and 2007–2008 periods.
Results: The incidence in 1985–1986 was 52/100,000 and in 2007–2008 was 45/100,000. In the group aged 20–75 years, the incidence decreased by 54% from 54/100000 in 1985–1986 to 25/100000 in 2007–2008 (P = 0.001) and increased by 49% in the group aged >75 years from 272/100000 to 406/100000 (P = 0.0001). The use of aspirin or nonsteroidal anti-inflammatory steroid drugs (NSAIDs) was 31% in 1985–1986 and increased to 67% in 2007–2008 (P = 0.004). In patients using aspirin or NSAIDs, Helicobacter pylori was present in 73% in 1995–1996 and in 51% in 2007–2008. H. pylori infection declined from 84% to 52% between 1995–1996 and 2007–2008.
Conclusions: The incidence rate of peptic ulcer bleeding did not change between 1985–1986 and 2007–2008, but decreased in the age group ≤75 years and increased in the age group >75 years. The use of low-dose aspirin and NSAIDs increased substantially over time, and H. pylori infection was still present in 51% of these patients in 2007–2008.
Keywords: epidemiology, peptic ulcer bleeding, time trends, risk factors
Readers of this article also read:
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives
Intestinal fermentation in patients with self-reported food hypersensitivity: painful, but protective?
Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
Editorial
New and emerging treatments for the prevention of recurrent diverticulitis
Update on celiac disease – etiology, differential diagnosis, drug targets, and management advances
Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Amino acid-responsive Crohn's disease: a case study
- Oropharyngeal Crohn’s disease
- Methylnaltrexone in the treatment of opioid-induced constipation
- Selected luminal mucosal complications of adult celiac disease




